Production and characterization of a human monoclonal antibody, reactive with a conserved epitope on gp41 of human immunodeficiency virus type I - PubMed (original) (raw)

Production and characterization of a human monoclonal antibody, reactive with a conserved epitope on gp41 of human immunodeficiency virus type I

V J Teeuwsen et al. AIDS Res Hum Retroviruses. 1990 Mar.

Abstract

A human Epstein-Barr virus-transformed lymphoblastoid B-cell line was generated from peripheral blood mononuclear cells (PBMC) of an asymptomatic human immunodeficiency virus type I (HIV-1) seropositive donor, which produces a human monoclonal antibody K14 (IgG1), reactive with an epitope on the transmembrane part (gp41) of the envelope glycoprotein of HIV-1. This monoclonal antibody reacts with a lysate of HIV-1-infected H9 cells, gradient purified HIV-1, and a vaccinia recombinant HIV-1 gp160 protein, but not with HIV-2 antigens in an enzyme-linked immunosorbent assay (ELISA). When used as an immobilized ligand in an immune affinity column, K14 selectively purifies gp41 from a HIV-1-infected H9 cell lysate. Although no reactivity was observed in ELISA with a panel of partially overlapping synthetic nonapeptides spanning the whole length of HIV-1 gp41, it was shown to react with recombinant envelope proteins, provided that they did contain amino acids 643-692: deletion of this part resulted in the disappearance of the reactivity. Testing of an extensive panel of the sera from HIV-1 seropositive or seronegative donors from Europe and Africa, including a selected group of donors before and after HIV-1 seroconversion, in a competition ELISA with horseradish peroxidase-conjugated K14, showed that the epitope recognized on gp41 is immunodominant and conserved. K14 does not neutralize HIV-1 infectivity or virus-mediated cell fusion, and does not mediate antibody-dependent cellular cytotoxicity.

PubMed Disclaimer

Cited by

Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein.
Earl PL, Broder CC, Doms RW, Moss B. Earl PL, et al. J Virol. 1997 Apr;71(4):2674-84. doi: 10.1128/JVI.71.4.2674-2684.1997. J Virol. 1997. PMID: 9060620 Free PMC article.
Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies.
Xu JY, Gorny MK, Palker T, Karwowska S, Zolla-Pazner S. Xu JY, et al. J Virol. 1991 Sep;65(9):4832-8. doi: 10.1128/JVI.65.9.4832-4838.1991. J Virol. 1991. PMID: 1714520 Free PMC article.
B cell responses to HIV and the development of human monoclonal antibodies.
Boyd JE, James K. Boyd JE, et al. Clin Exp Immunol. 1992 May;88(2):189-202. doi: 10.1111/j.1365-2249.1992.tb03061.x. Clin Exp Immunol. 1992. PMID: 1572084 Free PMC article. Review.
Cellular and humoral antigenic epitopes in HIV and SIV.
Nixon DF, Broliden K, Ogg G, Broliden PA. Nixon DF, et al. Immunology. 1992 Aug;76(4):515-34. Immunology. 1992. PMID: 1383131 Free PMC article. Review. No abstract available.
Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins.
Broliden PA, von Gegerfelt A, Clapham P, Rosen J, Fenyö EM, Wahren B, Broliden K. Broliden PA, et al. Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):461-5. doi: 10.1073/pnas.89.2.461. Proc Natl Acad Sci U S A. 1992. PMID: 1370580 Free PMC article.

Production and characterization of a human monoclonal antibody, reactive with a conserved epitope on gp41 of human immunodeficiency virus type I - PubMed (original) (raw)